Genprex, Inc.: Genprex Announces U.S. Patent for Reqorsa Gene Therapy in Combination with ...

Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ ...
Muscular Dystrophy News

New FDA Elevidys label limits use to DMD patients who can walk

The FDA updated prescribing information for Elevidys with new safety warnings and limiting its use to DMD patients who can ...